Related Experiment Video
Updated: Jun 21, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Perinatal outcome in high risk pregnancies
Nabila Zareen1, Sonia Naqvi, Nasreen Majid
1Department of Obstetrics and Gynaecology, Hamdard University Hospital, Karachi. drnzareen@gmail.com
Summary
High-risk pregnancies show double the perinatal mortality compared to low-risk pregnancies. However, neonatal complications were similar between groups, indicating a need for closer monitoring in high-risk cases.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Perinatal Health
Background:
- High-risk pregnancies present unique challenges to perinatal outcomes.
- Identifying risk factors is crucial for effective management and improved neonatal survival.
Purpose of the Study:
- To evaluate perinatal outcomes in high-risk pregnancies.
- To compare perinatal mortality, Apgar scores, birth weight, and neonatal complications between high-risk and low-risk pregnancies.
Main Methods:
- A cohort study was conducted comparing 162 high-risk (Group A) and 120 low-risk (Group B) pregnancies.
- Data collected included perinatal mortality, Apgar scores, birth weight, and neonatal complications within the first week post-birth.
- Risk factors such as anemia, pregnancy-induced hypertension, and preterm labor were identified in the high-risk group.
Main Results:
- High-risk pregnancies had significantly higher rates of stillbirths (7.40% vs. 0.84%) and early neonatal deaths (3.08% vs. 0%).
- Low birth weight was more prevalent in the high-risk group (35.80% vs. 3.33%).
- Lower Apgar scores at 1 and 5 minutes were observed in neonates from high-risk pregnancies.
Conclusions:
- Perinatal mortality is significantly elevated in high-risk pregnancies.
- Despite higher mortality, neonatal complications were not statistically different between high-risk and low-risk groups.
- This highlights the importance of targeted interventions and monitoring for high-risk pregnancies to reduce mortality.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...